GluB1

GluB1 is a protein subunit that belongs to the family of ionotropic glutamate receptors, which mediate fast excitatory neurotransmission in the central nervous system. The term GluB1 is often used in the context of vertebrate studies to designate one of the auxiliary proteins that associate with the main receptor complex, modulating its kinetic properties and pharmacological profile. The gene encoding GluB1 is typically designated as GRIA2 in mammals, although nomenclature may vary across species and research traditions.

Structurally, GluB1 consists of an extracellular ligand‑binding domain, a transmembrane segment that forms the ion channel pore, and a cytoplasmic C‑terminal tail that interacts with intracellular scaffolding proteins. The extracellular domain binds the neurotransmitter glutamate, triggering conformational changes that open the channel and allow the selective influx of Na⁺ and Ca²⁺ ions. Alternative splicing of the GluB1 transcript gives rise to isoforms with distinct C‑terminal sequences, influencing receptor trafficking and synaptic localization.

Functionally, GluB1‑containing receptors are widely expressed in the cerebral cortex, hippocampus, and cerebellum, where they contribute to synaptic plasticity, learning, and memory. The subunit confers characteristic properties such as rapid activation, desensitization, and calcium permeability. Mutations or dysregulation of GluB1 have been linked to neurological disorders, including epilepsy, amyotrophic lateral sclerosis, and certain neurodevelopmental conditions. Studies suggest that altered GluB1 expression can affect excitatory‑inhibitory balance and neuronal excitotoxicity.

Research on GluB1 continues to explore its role in receptor assembly, signaling cascades, and therapeutic targeting. Pharmacological agents that selectively modulate GluB1‑containing receptors are being investigated for potential use in neuroprotective strategies and the treatment of excitotoxic brain injury.